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Abstract
We identified three non-related patients manifesting a childhood-onset progressive neuromyopathy with congenital cataracts,
delayed walking, distal weakness and wasting, glaucoma and swallowing difficulties. Electrophysiology and nerve biopsies
showed a mixed axonal and demyelinating neuropathy, while muscle biopsy disclosed both neurogenic and myopathic
changes with ragged red fibers, and muscle MRI showed consistent features across patients, with a peculiar concentric disto-
proximal gradient of fatty replacement. We used targeted next generation sequencing and candidate gene approach to study
these families. Compound biallelic heterozygous variants, p.[(Pro648Arg)]; [(His932Tyr)] and p.[(Thr251Ile),(Pro587Leu)];
[(Arg943Cys)], were found in the three patients causing this homogeneous phenotype. Our report on a subset of unrelated
patients, that showed a distinct autosomal recessive childhood-onset neuromyopathy with congenital cataracts and glaucoma,
expands the clinical spectrum of POLG-related disorders. It also confirms the association between cataracts and neuropathy
with variants in POLG. Early onset cataract is otherwise rare in POLG-related disorders and so far reported only in a few
patients with the clinical pattern of distal myopathy or neuromyopathy.
Introduction
Mitochondrial disorders are among the most frequent
inherited metabolic diseases. Despite this, they are not
always readily recognized and correctly managed, being
extremely heterogeneous, both clinically and genetically.
Variants in POLG, which is the gene coding for DNA
polymerase gamma, an enzyme involved in the replication
of human mitochondrial DNA, are known to cause a wide
array of pathologies, ranging from progressive external
ophthalmoplegia (PEO) to fatal Alpers syndrome. More
than 200 disease causing variants in POLG inherited as
autosomal dominant or recessive traits have been published
[1]. Variants that affect function are scattered throughout
the coding region of POLG, and genotype–phenotype cor-
relation is not always predictable [2], with some exceptions
constituted by some common variants in the linker region,
such as the c.1399 G > A (p.(Ala467Thr)) which is known
to occur more frequently in the childhood-onset cases with
Alpers syndrome [3], the c.2243 G > C (p.(Trp748Ser))
related to recessive ataxia, and the c.1760 C > T (p.
(Pro587Leu)), that is often found on the same allele with the
c.752 C > T (p.(Thr251Ile)) [4] and whose main clinical
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picture is represented by recessive PEO [5, 6]. Likewise, the
majority of the variants causing dominant PEO seem to
cluster in the polymerase domain [5].
Lately, a new POLG-related phenotype characterized
by slowly progressive mitochondrial distal myopathy
and cataracts was described. This seems to be a relatively
rare entity reported in single cases with dominant inheri-
tance associated with cachexia [7–9]. Early onset cataract
appears to be very rare in POLG-mutated patients and
has been so far reported either in a few patients with
recessive POLG variants [5, 6] or, noteworthy, in 3 of the
above-mentioned distal myopathy patients harboring
dominant missense variants in exon 17, c.2687 T > G (p.
(Leu896Arg)) or involving a different amino acid change in
the same position (either p.(Tyr951Asn) or p.(Tyr951His))
[8, 9].
Here, we describe a distinct recessive childhood-onset
phenotype in three unrelated sporadic patients, partially
overlapping with the dominant mitochondrial distal myo-
pathy with cachexia, and characterized by sensory-motor
neuropathy, mitochondrial myopathy, congenital cataracts,
glaucoma and homogeneous findings on muscle imaging.
We also provide a summary of other published patients with
distal myopathy or neuromyopathy with cataracts and var-
iants in POLG.
Patients and methods
Patients
Patient 1 is followed at the Bambino Gesù Children’s
Research Hospital, while patients 2 and 3 are followed at
Clinica Las Condes, Chile. The patients’ families gave their
consent for publication of clinical information and pictures.
Informed consent from parents was obtained before the
molecular genetic diagnostic work-up. The Ethics Com-
mittee of the involved institutions approved the research
protocol.
Muscle and nerve biopsies
Frozen muscle sections from patient 1 were stained
according to standard procedures [10]. Analysis by electron
Fig. 1 Clinical and histopathological features. a–f Clinical manifes-
tations of patient 1 (a, b) patient 2 (c, d) and patient 3 (e, f) showing
similar aspects of severe distal amyotrophy and paralysis of hands and
feet; note gastrostomy in patient 2 (d). Figure g and h correspond to
muscle pathology of patient 1, with seriate sections stained for cyto-
chrome c oxidase (COX) (g) and succinate dehydrogenase (SDH) (h)
showing COX negative fibers with marked mitochondrial proliferation
on SDH staining. Figures i–l illustrate nerve pathology, with electron
microscopy images of patient 2 (i) obtained late in the disease course,
and of patient 1 (j, k) and light microscopy of semithin sections of
patient 1 obtained at early stages of the disease at age 9 years. (l)
Figure 1i shows a single myelinated axon with relative thin myelin;
this was a single myelinated axon found in the nerve biopsy of patient
2 at the age of 25 years, that besides showed a marked subtotal loss of
myelinated axons. Figure 1j shows a demyelinated fiber, and Fig. 1k
shows a demyelinated fiber with aspects of degeneration and myeli-
nophagia. Figure 1l shows reduced number of myelinated axons, some
of which show a thinner myelin in relation to the axonal diameter
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microscopy according to standard protocols was used for
better characterization of ultrastructural abnormalities of the
performed nerve biopsies.
To detect multiple deletions, long-PCR analysis in DNA
extracted from muscle biopsy of index patient 1, and, for
comparison, from another patient positive for single dele-
tion was performed. Forward primer-3.701 and backward
primer-16.042 were used.
Muscle magnetic resonance imaging (MRI)
Muscle MRI of the pelvis and lower limbs was performed
using conventional T1-weighted and STIR sequences on
1.5 T scanners according to a protocol previously reported
[11].
Molecular genetics
Genomic DNA was extracted from peripheral blood in
all patients using DNA Extraction Kit (Qiagen, Hilden,
Germany). A targeted next generation sequencing was
performed in patients 1 and 2 with an identical technical
setup of MyoCap but including all known genes for
neuropathies and motor neuron disorders [12].
Sanger sequencing was performed to confirm results
obtained by NGS analysis in patients 1 and 2 and to
investigate family members of the probands for the presence
of the variants identified. The genomic sequence of POLG
was used to design PCR primer pairs to amplify all 22
coding exons and flanking intronic regions, as previously
described [6]. Nucleotide sequence determination was per-
formed by cycle sequencing using a BigDye Terminator
DNA sequencing kit v3.1 (Applied Biosystems, Hercules,
CA, USA). DNA sequences were analyzed using Seqscape
software version 3.0 and the GenBank POLG sequence (ID
NM_002693.1).
All POLG variants reported in this study were entered
into the Leiden Open Variation Database (www.LOVD.nl/
POLG; patient IDs 00105907, 00105904, 00105903).
Results
Case presentations
Patient 1
This boy was born from non-consanguineous Southern
Italian parents, and underwent bilateral cataract surgery at
age 6 months. He manifested delayed walking ability and
progressive distal upper and lower limbs weakness. Dys-
phagia followed by strabismus and ptosis appeared at 12
and 15 years, respectively. At age 16, he presented an acute
glaucoma in the left eye, and since then he has been phar-
macologically treated. When last examined at age 20, he
was able to walk only with ankle-foot orthoses. He had
facial weakness, tongue hypotrophy, ptosis and strabismus
without ophthalmoparesis. Proximal upper and lower limb
strength was slightly reduced while distal muscles including
intrinsic hand ones were severely weak (Fig. 1a, b). Deep
tendon reflexes were absent, and sensation was normal. A
sural nerve biopsy performed at the age of 9 showed, on
semithin sections and electron microscopy, reduction of
myelinated axons, figures of myelin outfoldings and some
axons showing a thin myelin sheath for axonal diameter
(Fig. 1j–l). Electrophysiological examination at age 12
years showed a sensorimotor neuropathy with reduced
motor and sensory conduction velocities: sensory action
Fig. 2 Muscle MRI. T1-
weighted MRI images of thighs
and lower legs in patients 1 (a)
and 2 (b). Note the fatty
replacement that progresses
from outer to inner muscle
layers particularly evident in the
anterior thigh compartments
(arrows). In this context, there is
relative sparing of deeper
muscles such as adductor
magnus (asterisk) and tibialis
posterior (arrowheads)
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potential of the sural nerve was absent, peroneal nerve
conduction velocity was 10 m/s and compound muscle
action potential (CMAP) amplitude of extensor digitorum
brevis muscle was reduced at 0.3 mV. Brain MRI was
unremarkable.
Muscle MRI showed a pattern of fatty replacement that
was not selective for specific muscles but rather suggestive
of a distal-proximal and “concentric” gradient of fatty
replacement, with the outer part of each muscle more
involved than the inner part (Fig. 2).
Muscle biopsy disclosed the presence of both chronic
neurogenic and myopathic changes with ragged red fibers
(RRF) and multiple deletions of mitochondrial DNA (Fig.
1g, h, and Supplementary Information, Fig. 1).
Patient 2
This Chilean girl was born healthy at term from non-
consanguineous parents and underwent surgery for bilateral
cataracts at age 3 months. By 8 months of age she devel-
oped motor delay and walked with orthoses at age 4 years.
Electrophysiological examination performed at age 3 years
disclosed significant slowing of motor velocities in the
range of 25–35 m/s in median and ulnar nerves and 41 m/s
in peroneal nerves. The motor responses showed extremely
reduced amplitude of 0.2 mV in extensor digitorum brevis
and thenar muscles with normal sensory conductions of
sural and ulnar nerves. She underwent gastrostomy for
swallowing difficulties, and tracheostomy for respiratory
failure with recurrent infections at the age of 20 and 23
years, respectively. When last examined at age 25, she had
severe generalized muscle wasting with distal tetraparesis,
tongue atrophy, thick lips, marked bilateral exophthalmos,
ophthalmoparesis and bilateral blindness caused by acute
glaucoma at age 15 years (Fig. 1c, d). Cerebrospinal fluid
(CSF) analysis showed hyperproteinorrachia 3.15 g/l (nor-
mal 0.15–0.6) and the muscle biopsy performed at age 12
years described nonspecific myopathic changes but SDH/
COX staining was not performed. Brain MRI only detected
very mild cerebellar vermis atrophy. A nerve biopsy at age
25 years showed prominent axonal loss with secondary
myelin abnormalities in very few residual axons on electron
microscopy (Fig. 1i).
Patient 3
This Chilean girl was born at term from non-
consanguineous parents. She was unrelated with the pre-
vious family, coming from a different geographical area.
She was evaluated elsewhere for the first time at 24 months
of age by a pediatric neurologist since developmental delay
and hypotonia was manifest. Only at this evaluation bilat-
eral cataracts were detected and addressed to
ophthalmologist. At that time a muscle biopsy described
myopathic changes with RRF. CSF analysis disclosed
normal lactate and elevated protein levels 6.5 g/l, which led
to the diagnosis of chronic inflammatory demyelinating
neuropathy. She was treated with intravenous immunoglo-
bulins without clinical improvement. Nerve conduction
velocity studies performed at age 9 were consistent with a
sensory-motor neuropathy. Absent sural nerve action
potentials, prolonged distal latency on median and peroneal
nerves, reduced CMAP amplitude (0.1–0.2 mV in extensor
digitorum brevis and thenar muscles, respectively), and
slowing of conduction velocities (9–15 m/s) were detected.
At age 12 years, she underwent corneal implant on the right
eye following an acute glaucoma with corneal damage. She
was investigated for lack of development of secondary
sexual characters with a diagnosis of functional hypogo-
nadotropic hypogonadism. When re-evaluated at 16 years
her hands were paretic and severely atrophied, adopting a
fixed supine posture with the palms of the hands facing
permanently upwards without proximal radioulnar joint
movements (Fig. 1e, f). Mild ptosis, ophthalmoparesis, and
facial weakness were also present. Muscle MRI features
were very similar to patient 1 (Fig. 2). Brain MRI was
normal.
None of our patients showed any clinical sign or
laboratory finding suggestive of ataxia, epilepsy, or
hepatopathy.
Molecular genetic analyses
Using a candidate gene approach in patient 1, based on
clinical and electrophysiological findings, variants in DNM2
and MFN2 were first ruled out by direct sequencing. Tar-
geted next generation sequencing then detected two mis-
sense variants in POLG: c.1943C > G (p.(Pro648Arg)) in
exon 10 and c.2794 C > T (p.(His932Tyr)) in exon 18
(exons are numbered like in reference [6) that were con-
firmed by Sanger sequencing and segregated on two dif-
ferent alleles in the parents. In patient 2 direct sequencing
ruled out variants in DNM2, responsible of a form of neu-
ropathy and cataracts [13], in CTDP1 [14], and MTMR2,
known to cause the Charcot-Marie Tooth type 4B variant
with thick lips [15]. Later, the same next generation
sequencing approach identified the c.2827 C > T (p.
(Arg943Cys)) variant in exon 18. Given the similarity of the
phenotype with patient 1, Sanger sequencing was performed
to complete the POLG sequence that was not entirely
covered by NGS approach and two other variants, c.1760 C
> T (p.(Pro587Leu)) in exon 10 and c.752 C > T (p.
(Thr251Ile)) in exon 3, were found on the other allele,
segregating appropriately in parents.
Patient 3 showed very similar clinical features so POLG
was directly sequenced finding the same compound
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heterozygous variants of patient 2, c.1760 C > T (p.
(Pro587Leu)), in cis with the c.752 C > T (p.(Thr251Ile)),
and c.2827 C > T (p.(Arg943Cys)) (Supplementary Infor-
mation, Fig. 2). The patients’ parents were heterozygous
carriers of the identified variants.
Table 1 summarizes the features of our patients and of
other patients reported as affected by a distal myopathy or
neuromyopathy, associated with early onset cataracts and
variants in POLG.
Discussion
We identified three patients with compound heterozygous
variants in POLG causing a homogeneous phenotype of
severe neuromyopathy with cataracts and glaucoma.
These patients harbor a combination of variants in POLG
exons 18 and 10. The c.1760 C > T (p.(Pro587Leu)) is
associated in two patients with another variant in exon 3 on
the same allele: c.752 C > T (p.(Thr251Ile)). This allele is
reported among the most frequently and widely described
POLG variants [3, 6, 16, 17, 18], and the two substitutions
are thought to act synergistically to affect POLG function
[18].
In all three patients the onset was characterized by very
early cataracts, delayed walking and distal weakness. Later
in the second decade all patients developed glaucoma.
Muscle biopsy showed myopathic or mixed myopathic and
neurogenic findings with RRF, and muscle MRI showed
consistent features across patients. The polyneuropathy in
these patients is characterized by a sensory-motor, pre-
dominantly axonal with associated demyelinating involve-
ment, associated with a severe distal muscle atrophy
progressing into paralysis of hands and feet. Electro-
physiological examinations showed that motor and sensory
conduction velocities were markedly slowed with reduced
CMAP amplitude in distal muscles of the legs. This poly-
neuropathy was concomitant with a primary mitochondrial
myopathy characterized by slightly elevated CK levels,
RRF, and multiple mitochondrial DNA deletions on muscle
biopsy. Cachexia was also a typical feature, probably due to
dysphagia as well as to the progressive neuromyopathy.
Hyperproteinorrachia in CSF was also a feature, and
hypogonadism, that was present in one of our patients, has
been reported in association with early onset cataracts in a
single patient with a heterozygous variant in POLG [9]. No
additional manifestations reported in POLG-related dis-
orders were observed: patients had a normal intelligence,
with a substantially normal brain MRI, without epilepsy or
heart involvement.
Congenital cataract represents a rare feature reported in
other neurological/neuromuscular disorders such as
Marinesco-Sjogren syndrome and congenital cataracts and
facial dysmorphism (CCFDN) but rarely associated with
POLG variants [5, 6, 8, 9]. Interestingly, the c.2827 C > T
(p.(Arg943Cys)) variant in the Chilean patients of our
cohort, already associated with PEO and parkinsonism
combined with a variant in the exonuclease domain of
POLG [19], has been also described in a young girl with
developmental delay, dysmorphic features, and congenital
cataract in association with a variant in the linker region
domain [6]. Early onset cataract has been also reported in
another patient with primary ovarian failure and PEO har-
boring a dominant variant (c.2828 G > A) affecting the same
Arg943 residue (p.(Arg943His)) [16]. This finding might
suggest a genotype–phenotype correlation between this
clinical feature and this arginine residue in the polymerase
domain, which is known to be involved in binding the
oxygen atoms of the gamma-phosphate of the incoming
dNTP and in helping to position the incoming dNTP for
catalysis [6].
The association of glaucoma and cataracts is unique and
has not been so far related to POLG. A possible link
between mitochondrial dysfunction and pathogenesis of
glaucoma-induced blindness is provided by recent evi-
dences suggesting that retinal ganglion cells, that are par-
ticularly dependent on mitochondrial metabolism, are also
highly susceptible to damage in open-angle glaucoma.
Oxidative injury inducing vascular alterations of the optic
nerve or causing dysfunctions of the trabecular meshwork
with consequent aqueous humor outflow impairment are
additional factors contributing to the pathogenesis of glau-
coma [20, 21].
The differential diagnosis of this distinct syndrome
includes the neuropathy with CCFDN associated with a
founder variant in CTDP1 in the gypsies [14]. In this dis-
ease, however, the neuropathy is purely demyelinating and
glaucoma is absent. Similarly, variants in DNM2 can cause
neuropathy, myopathy, and cataracts without glaucoma
[13]. Variants in two myotubularin-related genes, namely
MTMR2 and MTMR13, cause demyelinating neuropathy
with myelin outfoldings, facial, and bulbar weakness
(CMT4B1) or with glaucoma but no cataracts (CMT4B2)
[15]. In our patients, concomitant variants in these genes
were excluded either by direct sequencing or because these
genes were included in the next generation sequencing
panel.
The phenotype we described also shares some features
with the reported POLG-distal myopathy with cataracts
(Table 1). In our literature review of this condition, we
found that three patients out of four showed onset of cat-
aracts in childhood, while one had later onset, and none of
them had a neuropathy. Heterozygous dominant variants
were detected in all unrelated individuals, all were located
in exons 17 or 18 of the polymerase domain, and two of
these variants changed the same Tyr951 residue with a
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different amino acid (Histidine and Asparagine). Interest-
ingly, all of our three patients also showed one hetero-
compound variant in exon 18. Tang and collaborators [5]
also described two patients harboring the same exon 18
variant of patient 1, c.2794 C > T (p.(His932Tyr)), in com-
bination with the same in cis variants of patients 2 and 3 c.
[1760 C > T; 752 C > T] (p.(Pro587Leu); (Thr251Ile)).
Interestingly, these patients share several clinical features
with ours, such as neuromyopathy, and cataracts in one case
but not glaucoma (Table 1).
Of note, muscle imaging was similar in two of our
patients, consistently displaying the concentric and disto-
proximal gradient, which is reminiscent of the pattern
described in distal myopathy patients with dominant POLG
variants [8, 22]. This MRI pattern, which is unique and not
reported in any other neuromuscular disorder, could be
considered as a recognizable biomarker to prioritize a
genetic screening of POLG in undiagnosed patients with
neuropathy or distal myopathy.
In conclusion, this report expands the clinical spectrum
of POLG-related disorders, and identifies a distinct pheno-
type of severe neuromyopathy with congenital cataracts and
glaucoma. Intraocular pressure should be carefully mea-
sured in patients with POLG variants because all of them
may be at risk of developing overt glaucoma, and anti-
oxidant drugs might have a protective effect on glaucoma-
induced optic nerve damage in these patients.
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